Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists

Digestive Diseases and Sciences

Volumn 56, Issue 2, 2011, Pages 569-577

  Sharma, Pratima ^a   Saini, Sameer D ^a,b   Kuhn, Latoya B ^a,b   Rubenstein, Joel H ^a,b   Pardi, Darrell S ^c   Marrero, Jorge A ^a   Schoenfeld, Philip S ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Hepatocellular carcinoma; Outcomes; Survey

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LAW SUIT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MALPRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; SCREENING TEST;

CARCINOMA, HEPATOCELLULAR; DATA COLLECTION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; GASTROENTEROLOGY; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LIVER NEOPLASMS; MALE; MASS SCREENING; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK FACTORS;

EID: 79952455428     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1453-5     Document Type: Article

References (25)

1. DK Espey XC Wu J Swan C Wiggins MA Jim E Ward PA Wingo HL Howe LA Ries BA Miller A Jemal F Ahmed N Cobb JS Kaur BK Edwards 2007 Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska natives Cancer 110 2119 2152 10.1002/cncr.23044 17939129 (Pubitemid 350100734)
2. HB El-Serag JA Davila NJ Petersen KA McGlynn 2003 The continuing increase in the incidence of hepatocellular carcinoma in the united states: an update Ann Intern Med 139 817 823 14623619
3. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 1:STN:280:DyaK1M7ls1ensg%3D%3D 10.1056/NEJM199903113401001 10072408 (Pubitemid 29114292)
4. RF Velazquez M Rodriguez CA Navascues A Linares R Perez NG Sotorrios I Martinez L Rodrigo 2003 Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 520 527 10.1053/jhep.2003.50093 12601348 (Pubitemid 36258772)
5. H Tsukuma T Hiyama S Tanaka M Nakao T Yabuuchi T Kitamura K Nakanishi I Fujimoto A Inoue H Yamazaki, et al. 1993 Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1797 1801 1:STN:280:DyaK3s3nsFektg%3D%3D 10.1056/NEJM199306243282501 7684822 (Pubitemid 23174709)
6. JA Marrero RJ Fontana GL Su HS Conjeevaram DM Emick AS Lok 2002 Nafld may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 1349 1354 12447858 (Pubitemid 35403524)
7. V Mazzaferro E Regalia R Doci S Andreola A Pulvirenti F Bozzetti F Montalto M Ammatuna A Morabito L Gennari 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 1:STN:280:DyaK287nsFWltw%3D%3D 10.1056/NEJM199603143341104 8594428 (Pubitemid 26079803)
8. BH Zhang BH Yang ZY Tang 2004 Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 417 422 15042359
9. S Shiina T Teratani S Obi S Sato R Tateishi T Fujishima T Ishikawa Y Koike H Yoshida T Kawabe M Omata 2005 A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 122 130 10.1053/j.gastro.2005.04.009 16012942 (Pubitemid 41002049)
10. RA Lencioni HP Allgaier D Cioni M Olschewski P Deibert L Crocetti H Frings J Laubenberger I Zuber HE Blum C Bartolozzi 2003 Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection Radiology 228 235 240 10.1148/radiol.2281020718 12759473 (Pubitemid 36736097)
11. J Bruix JM Llovet A Castells X Montana C Bru MC Ayuso R Vilana J Rodes 1998 Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1578 1583 1:STN:280:DyaK1c3otFKnsg%3D%3D 10.1002/hep.510270617 9620330 (Pubitemid 28264682)
12. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc AC de Oliveira A Santoro JL Raoul A Forner M Schwartz C Porta S Zeuzem L Bolondi TF Greten PR Galle JF Seitz I Borbath D Haussinger T Giannaris M Shan M Moscovici D Voliotis J Bruix 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 1:CAS:528:DC%2BD1cXovFWjsL8%3D 10.1056/NEJMoa0708857 18650514
13. PM Lopez A Villanueva JM Llovet 2006 Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials Aliment Pharmacol Ther 23 1535 1547 1:STN:280: DC%2BD283mslensw%3D%3D 10.1111/j.1365-2036.2006.02932.x 16696801 (Pubitemid 43727460)
14. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)
15. JH Rubenstein SD Saini L Kuhn L McMahon P Sharma DS Pardi P Schoenfeld 2008 Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus Am J Gastroenterol 103 842 849 10.1111/j.1572-0241.2007.01689.x 18076733 (Pubitemid 351501086)
16. SD Saini RS Nayak L Kuhn P Schoenfeld 2009 Why don't gastroenterologists follow colon polyp surveillance guidelines? Results of a national survey J Clin Gastroenterol 43 554 558 10.1097/MCG.0b013e31818242ad 19542818
17. P Sharma V Balan JL Hernandez AM Harper EB Edwards H Rodriguez-Luna T Byrne HE Vargas D Mulligan J Rakela RH Wiesner 2004 Liver transplantation for hepatocellular carcinoma: the MELD impact Liver Transpl 10 36 41 10.1002/lt.20012 14755775 (Pubitemid 38885890)
18. L Bolondi S Sofia S Siringo S Gaiani A Casali G Zironi F Piscaglia L Gramantieri M Zanetti M Sherman 2001 Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis Gut 48 251 259 1:STN:280:DC%2BD3M7is1WnsQ%3D%3D 10.1136/gut.48.2.251 11156649 (Pubitemid 32141852)
19. B Zhang B Yang 1999 Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer J Med Screen 6 108 110 1:STN:280:DyaK1MzntlOmtQ%3D%3D 10444731 (Pubitemid 29320849)
20. A Singal ML Volk A Waljee R Salgia P Higgins MA Rogers JA Marrero 2009 Meta-analysis: surveillance with ultrasound for early stage hepatocellular carcinoma in patients with cirrhosis Aliment Pharmacol Ther 30 37 47 1:STN:280:DC%2BD1MvltlyqtQ%3D%3D 10.1111/j.1365-2036.2009.04014.x 19392863
21. M Sherman 2001 Alphafetoprotein: an obituary J Hepatol 34 603 605 1:STN:280:DC%2BD3Mzis1GitA%3D%3D 10.1016/S0168-8278(01)00025-3 11394662 (Pubitemid 32328519)
22. JA Marrero Z Feng Y Wang MH Nguyen AS Befeler LR Roberts KR Reddy D Harnois JM Llovet D Normolle J Dalhgren D Chia AS Lok PD Wagner S Srivastava M Schwartz 2009 Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma Gastroenterology 137 110 118 1:CAS:528:DC%2BD1MXovFOgsbs%3D 10.1053/j.gastro.2009.04.005 19362088
23. N Chalasani A Said R Ness H Hoen L Lumeng 1999 Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey Am J Gastroenterol 94 2224 2229 1:STN:280:DyaK1Mznt1OhtA%3D%3D 10.1111/j.1572-0241.1999.01297.x 10445554 (Pubitemid 29374558)
24. JG Chen DM Parkin QG Chen JH Lu QJ Shen BC Zhang YR Zhu 2003 Screening for liver cancer: results of a randomised controlled trial in Qidong, China J Med Screen 10 204 209 10.1258/096914103771773320 14738659 (Pubitemid 38091209)
25. TT Nguyen G Gildengorin A Truong SJ McPhee 2007 Factors influencing physicians' screening behavior for liver cancer among high-risk patients J Gen Intern Med 22 523 526 10.1007/s11606-007-0128-1 17372804 (Pubitemid 46941211)